Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

News and Insights

Showing items 1 to3 of 6

Playlist Category
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
FDA approves highly anticipated first-in-class drug for schizophrenia: BMS' Cobenfy
Insight
Our Take Newsletter
September 30, 2024

FDA approves highly anticipated first-in-class drug for schizophrenia: BMS' Cobenfy

Learn More
September 30, 2024
Pharma strategy, engagement, and market access
FTC sues 3 largest PBMs and their GPOs, alleging they inflated insulin prices
Insight
Our Take Newsletter
September 23, 2024

FTC sues 3 largest PBMs and their GPOs, alleging they inflated insulin prices

Learn More
September 23, 2024
Pharmacy, PBMs and drug pricing
Senate committee to vote on holding Steward Health Care CEO in contempt for refusing to testify at hearing
Insight
Our Take Newsletter
September 16, 2024

Senate committee to vote on holding Steward Health Care CEO in contempt for refusing to testify at hearing

Learn More
September 16, 2024
IDN trends, challenges, and leadership
Pfizer launches digital DTC platform, following Eli Lilly's lead
Insight
Our Take Newsletter
September 9, 2024

Pfizer launches digital DTC platform, following Eli Lilly's lead

Learn More
September 9, 2024
Digital health and emerging technologies
Our Take: Ohio AG sues Cigna, Humana, Prime Therapeutics and others, alleging PBMs engaged in price fixing
Insight
Our Take Newsletter
April 3, 2023

Our Take: Ohio AG sues Cigna, Humana, Prime Therapeutics and others, alleging PBMs engaged in price fixing

Learn More
April 3, 2023
Pharmacy, PBMs and drug pricing
Our Take: Biogen’s aducanumab gets a second life
Insight
Our Take Newsletter
October 28, 2019

Our Take: Biogen’s aducanumab gets a second life

Learn More
October 28, 2019
Health policy, CMS initiatives and health economics
Our Take: Sutter Health agrees to tentative settlement in antitrust trial
Insight
Our Take Newsletter
October 21, 2019

Our Take: Sutter Health agrees to tentative settlement in antitrust trial

Learn More
October 21, 2019
IDN trends, challenges, and leadership
Our Take: CMS, HHS propose rules to ease restrictions imposed by Stark Law, anti-kickback statute
Insight
Our Take Newsletter
October 14, 2019

Our Take: CMS, HHS propose rules to ease restrictions imposed by Stark Law, anti-kickback statute

Learn More
October 14, 2019
Health policy, CMS initiatives and health economics
Our Take: 2018 MSSP performance data released by CMS
Insight
Our Take Newsletter
October 7, 2019

Our Take: 2018 MSSP performance data released by CMS

Learn More
October 7, 2019
Health policy, CMS initiatives and health economics
Our Take: Judge rules against Johnson & Johnson in landmark opioid case
Insight
Our Take Newsletter
September 9, 2019

Our Take: Judge rules against Johnson & Johnson in landmark opioid case

Learn More
September 9, 2019
Health policy, CMS initiatives and health economics
Our Take: Independent pharmacy network rated highest in customer satisfaction
Insight
Our Take Newsletter
August 26, 2019

Our Take: Independent pharmacy network rated highest in customer satisfaction

Learn More
August 26, 2019
Pharmacy, PBMs and drug pricing
Our Take: Commercial ACOs top 3,000 agreements, 30 million members
Insight
Our Take Newsletter
August 19, 2019

Our Take: Commercial ACOs top 3,000 agreements, 30 million members

Learn More
August 19, 2019
Value-based care and alternative payment models
Stay Aware. Stay Informed.

Want to stay ahead of health care trends?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.